SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

FERMENTA BIOTECH

BSE: 506414 19 Aug 2025
Healthcare
₹ 346.25
FERMENTA BIOTECH LIMITED specializes in Pharmaceuticals within the Healthcare sector.

FERMENTA BIOTECH - Share Price & Details

Market Cap
₹1,042
High /Low
449.0 / 219.0
Stock P/E
9.97
Book Value
₹123.0
Dividend Yield
0.71
ROCE
23.0
ROE
₹24.9
Face Value
5.0
PEG Ratio
0.14
EVEBITDA
₹7.0
Debt
115
CMP / FCF
15.6
Debt to equity
₹0.32
NP Ann
76.4
High price all time
449.0
Piotroski score
₹8.0
Graham Number
314.0
No. Eq. Shares
2.94
Net CF
₹-10.1
Net profit
104
Price to book value
2.88
Interest Coverage
₹9.45
Low price all time
7.76
Industry PE
33.8
Reserves
₹348
Free Cash Flow
₹38.0

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
FERMENTA BIOTECH LIMITED1,259.21293.111,220.3810.051,0429.97
THEMIS MEDICARE LTD.987.54-153.74975.78-1.67102634.4
Bharat Parenterals Limited825.4022.80802.803.4897340.1

Peer Comparison Chart


About FERMENTA BIOTECH

FERMENTA BIOTECH LIMITED, with Security Code 506414, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Fermenta Biotech Reports Significant Growth Amid Mixed Financial Performance in June 2025

(14 Aug 2025)
Fermenta Biotech's financial results for the quarter ending June 2025 highlight significant growth, with Profit Before Tax reaching Rs 19.32...
Read more →

Fermenta Biotech reports consolidated net profit of Rs 21.83 crore in the June 2025 quarter

(13 Aug 2025)
Net profit of Fermenta Biotech reported to Rs 21.83 crore in the quarter ended June 2025 as against net loss of Rs 5.82 crore during the...
Read more →

Fermenta Announces Granting of CEP by EDQM for VITADEE™ 100 SD Enabling Accelerated Global Growth

(04 Aug 2025)
THANE, India, July 30, 2025 /PRNewswire/ -- Fermenta Biotech Limited ('Fermenta'), a pioneer in pharmaceutical and nutritional ingredients;...
Read more →

Is Fermenta Biotech Limited (506414) a Good Long Term Bet - Get exclusive access to premium stock research

(03 Aug 2025)
Is Fermenta Biotech Limited (506414) a Good Long Term Bet ✌️【Stock Buzz】✌️ Tap into the same insights top investors use to gain a strategic...
Read more →

Can Fermenta Biotech Limited (506414) Maintain Its Valuation - Accelerated profit realization

(03 Aug 2025)
Can Fermenta Biotech Limited (506414) Maintain Its Valuation ✌️【Market Focus】✌️ Whether you're a beginner or seasoned investor, our platform...
Read more →

Fermenta receives CEP by EDQM for Vitadee 100 SD

(31 Jul 2025)
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3. Fermenta Biotech Limited...
Read more →

Company Updates